Traditional herbal registration: simplified registration for traditional herbal medicinal products

Traditional herbal registration is the simplified EU route for herbal medicines with at least 30 years of medicinal use, 15 of them in the EU.

Also known as: traditional use registration, TUR, THMP registration

4 min readUpdated

Reviewed by Gosia Luksza, CEO at Regunaut

At a glance

Legal basis
Articles 16a to 16i of Directive 2001/83/EC
Evidence of use
30 years of medicinal use, at least 15 of them in the EU
Granted by
National competent authorities
Limits
Oral, external or inhalation use, without medical supervision

How it works

Articles 16a to 16i of Directive 2001/83/EC, inserted by Directive 2004/24/EC, create a simplified registration for traditional herbal medicinal products. It exists because many herbal products have a long history of use but lack the published evidence needed for a well-established use application, let alone a full dossier. Instead of clinical trials, the applicant shows that the product, or a corresponding product, has been in medicinal use for at least 30 years before the application, including at least 15 years in the EU, that it is not harmful under the specified conditions of use, and that its pharmacological effects or efficacy are plausible on the basis of long-standing use and experience.

Article 16a(1) limits the route. The indications must be suitable for use without a doctor's supervision for diagnosis, prescription or monitoring; the product must be given at a specified strength and posology; and it must be for oral, external or inhalation use. Vitamins and minerals may be included if their action is ancillary to that of the herbal ingredients. A product that qualifies for a marketing authorisation, or for registration as a homeopathic product, cannot use the route. The quality requirements are not simplified: the dossier needs full quality documentation, as for any other medicine, and manufacture must comply with good manufacturing practice.

The Committee on Herbal Medicinal Products (HMPC) at EMA supports the route in two ways. It adopts EU herbal monographs, which set out the committee's view on the traditional or well-established use of a herbal substance or preparation, and it prepares entries for the EU list of herbal substances, preparations and combinations under Article 16f, which the Commission adopts. An applicant whose product matches a list entry does not have to prove the period of traditional use or the safety again. Registrations are national. Mutual recognition and the decentralised procedure are available where an EU herbal monograph exists or the product is on the list; otherwise each Member State takes due account of registrations granted elsewhere. Labelling, the leaflet and advertising must state that the product is a traditional herbal medicinal product for use in the specified indications exclusively based on long-standing use, and the user is told to consult a doctor if symptoms persist.

What goes wrong

Evidence of 30 years' use that concerns a different preparation, extraction solvent or strength from the product applied for; fewer than 15 years of use in the EU, which sends the file to the HMPC under Article 16c(4); indications that imply medical diagnosis or supervision; combinations for which the evidence of traditional use covers the individual ingredients but not the combination; and quality dossiers that fall short on the identity and consistency of the herbal preparation. Registered products carry the same pharmacovigilance and manufacturing obligations as authorised medicines, which small applicants often underestimate.

Timing

Registration is a national procedure, and Article 17(1) of the Directive applies by analogy, so the authority has 210 days from a valid application. Where an EU herbal monograph or a list entry exists, the decentralised and mutual recognition timetables can be used. A referral to the HMPC under Article 16c(4), for a product with less than 15 years of use in the EU, adds the time the committee needs to consider it.

Traditional herbal registration: common questions

What is the 30-year rule for traditional herbal medicines?

The applicant must show that the product, or a corresponding product, has been in medicinal use for at least 30 years before the application, including at least 15 years in the EU. The evidence can be bibliographic or expert. If use in the EU is shorter than 15 years but the product otherwise qualifies, the Member State refers it to the HMPC.

What is the difference between traditional use and well-established use for herbal medicines?

Well-established use leads to a marketing authorisation under Article 10a and needs published scientific evidence of efficacy and safety, with at least ten years of use in the EU. Traditional use leads to a registration under Article 16a, needs no clinical evidence and rests on 30 years of use with plausible efficacy. An HMPC monograph can cover either or both for the same herbal substance.

Can a traditional herbal registration be recognised in other Member States?

Yes, in two cases: where the HMPC has established an EU herbal monograph for the substance or preparation, or where the product consists of substances on the EU list adopted under Article 16f. Mutual recognition and the decentralised procedure then apply. In other cases each Member State decides for itself but must take due account of registrations granted by others.

Sources

  1. EUR-Lex: Directive 2004/24/EC on traditional herbal medicinal products, amending Directive 2001/83/EC
  2. EUR-Lex: Directive 2001/83/EC on the Community code relating to medicinal products for human use
  3. European Medicines Agency: Herbal medicinal products
  4. European Medicines Agency: Committee on Herbal Medicinal Products (HMPC)

Put your Traditional herbal registration question to Workbench

Workbench answers regulatory questions from EUR-Lex, EMA, national agencies and your own documents, with every claim linked to its source. Start free with welcome credits.